Grants
Geoff Smith (School of Pharmacy) has been collaborating with various industrial partners on Innovate UK-funded collaborative R&D projects since 2008. These projects (LyoDEA, 2008-2012 and BioStart, 2014-2018) have led to the development of a novel instrumentation technology (Through Vial Impedance Spectroscopy, TVIS) for the optimization of production-cycles for freeze-dried, injectable medicines (proteins, antibiotics, vaccines etc.). Our next project grant, AtlasBio, will enable º£½ÇÉçÇø to develop a non-contact version of the TVIS technology (NC-TVIS). In parallel with TVIS, we are developing other instrumentation technology for formulation screening, including a novel freeze-drying microscope, via our FastLyo programme with Biopharma Process Solutions.
LyoDEA (grant ref. )
£217 160 Collaborative R&D
November 1 2008 to October 31 2012
Funding body : Technology Strategy Board
Partners: GEA, BlueFrog, AstraZeneca, Ametek,
º£½ÇÉçÇø
|
![Fast_Lyo_Logo](/webimages/Health-and-Life-Sciences-images/TVIS/Fast-Lyo-Logo.jpg) |
BioStaRT (grant ref. )
£367 567 Collaborative R&D
August 1 2014 to Jan 31 2018
Funding body : Innovate UK
Partners: GEA, BlueFrog, Sanofi (Ireland)
National Institute for Biological Standards and Control,
Nottingham University, º£½ÇÉçÇø
|
![Atlas_Bio_Logo](/webimages/Health-and-Life-Sciences-images/TVIS/Atlas-Bio-Logo.jpg) |
AtlasBio (grant ref. )
£803 846 Collaborative R&D
February 1 2017 to January 31 2020
Funding body : Innovate UK
Partners: GEA, BlueFrog, CPI,
OnkoLytika, IS Instruments, Ocean Optics,
National Institute for Biological Standards and Control,
Nottingham University, º£½ÇÉçÇø
|
|
FastLyo (grant ref. )
£99,849 Feasibility Study
February 1 2018 to January 31 2019
Funding body : Innovate UK
Partners: Biopharma Process Solutions,
OnkoLytika, º£½ÇÉçÇø
|
|